| Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/chow feeding choice task EJ Nunes, PA Randall, A Estrada, B Epling, EE Hart, CA Lee, Y Baqi, ... Psychopharmacology 231, 727-736, 2014 | 111 | 2014 |
| Clinical, virologic, and immunologic evaluation of symptomatic coronavirus disease 2019 rebound following nirmatrelvir/ritonavir treatment BP Epling, JM Rocco, KL Boswell, E Laidlaw, F Galindo, A Kellogg, S Das, ... Clinical Infectious Diseases 76 (4), 573-581, 2023 | 39 | 2023 |
| Polyuria and cerebral vasospasm after aneurysmal subarachnoid hemorrhage RJ Brown, BP Epling, I Staff, G Fortunato, JJ Grady, LD McCullough BMC neurology 15, 1-7, 2015 | 31 | 2015 |
| Long-term Outcomes of Patients With HIV and Pneumocystis jirovecii Pneumonia in the Antiretroviral Therapy Era BP Epling, M Manion, A Sirajuddin, E Laidlaw, F Galindo, M Anderson, ... Open forum infectious diseases 10 (8), ofad408, 2023 | 2 | 2023 |
| Prolonged mpox disease in people with advanced HIV: characterization of mpox skin lesions J O’Shea, J Zucker, S Stampfer, S Cash-Goldwasser, FS Minhaj, A Dretler, ... The Journal of Infectious Diseases 229 (Supplement_2), S243-S248, 2024 | 1 | 2024 |
| Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patients A Pérez-Díez, X Liu, S Calderon, A Bennett, A Lisco, A Kellog, F Galindo, ... Frontiers in immunology 15, 1352330, 2024 | | 2024 |
| Immune responses to SARS-CoV-2 mRNA vaccination in people with idiopathic CD4 lymphopenia JM Rocco, KL Boswell, E Laidlaw, B Epling, M Anderson, L Serebryannyy, ... Journal of Allergy and Clinical Immunology 153 (2), 503-512, 2024 | | 2024 |
| Lack of Evidence for a Role of ACE-2 Polymorphisms as a Bedside Clinical Prognostic Marker of COVID-19 JR Fiore, M Di Stefano, A Oler, Y Zhang, J Gu, CL Dalgard, G Faleo, ... Viruses 15 (7), 1448, 2023 | | 2023 |
| Cefiderocol and the need for higher-quality evidence: methods matter for patients BP Epling, JH Powers III Antimicrobial Agents and Chemotherapy 66 (8), e00766-22, 2022 | | 2022 |
